Literature DB >> 24568978

Office probing for treatment of nasolacrimal duct obstruction in infants.

Aaron M Miller1, Danielle L Chandler2, Michael X Repka3, Darren L Hoover4, Katherine A Lee5, Michele Melia2, Paul J Rychwalski6, David I Silbert7, Roy W Beck, Eric R Crouch, Sean Donahue, Jonathan M Holmes, Graham E Quinn, Nick A Sala, Susan Schloff, David K Wallace, Nicole C Foster, Kevin D Frick, Richard P Golden, Scott R Lambert, D Robbins Tien, David R Weakley.   

Abstract

PURPOSE: To determine whether demographic or clinical factors are associated with the outcome of office-based nasolacrimal duct probing for the treatment of congenital nasolacrimal duct obstruction (NLDO).
METHODS: In two multicenter prospective studies, 384 eyes of 304 children aged 6 to <15 months with NLDO underwent a nasolacrimal duct probing performed in the office using topical anesthesia. Treatment success, defined as no clinical signs of NLDO (epiphora, increased tear lake, or mucous discharge) and no reoperation, was assessed 1 month after probing in one study and 6 months after probing in the other study. Data from both studies were pooled to evaluate associations between baseline characteristics and treatment success.
RESULTS: Office probing was successful in 75% of eyes overall (95% CI, 70%-80%). The procedure was less successful in eyes of children with bilateral NLDO compared with unilateral NLDO (63% vs 80%; relative risk = 0.78 [95% CI, 0.66-0.92]) and in eyes that had 2 or 3 clinical signs of NLDO compared with one (71% vs 83%; relative risk = 0.88 [95% CI, 0.81-0.96]). Treatment success did not appear to be related to age, specific clinical signs of NLDO, prior treatment, or research study.
CONCLUSIONS: Performing nasolacrimal duct probing in the office successfully treats NLDO in the majority of cases in children aged 6 to <15 months. The success rate is lower with bilateral disease or when more than one clinical sign of NLDO is present.
Copyright © 2014 American Association for Pediatric Ophthalmology and Strabismus. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24568978      PMCID: PMC3936253          DOI: 10.1016/j.jaapos.2013.10.016

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  20 in total

1.  A modified poisson regression approach to prospective studies with binary data.

Authors:  Guangyong Zou
Journal:  Am J Epidemiol       Date:  2004-04-01       Impact factor: 4.897

2.  Dacryostenosis.

Authors:  H W PRICE
Journal:  J Pediatr       Date:  1947-03       Impact factor: 4.406

3.  DACRYOCYSTITIS IN INFANCY.

Authors:  O O Ffooks
Journal:  Br J Ophthalmol       Date:  1962-07       Impact factor: 4.638

4.  Epiphora during the first year of life.

Authors:  C J MacEwen; J D Young
Journal:  Eye (Lond)       Date:  1991       Impact factor: 3.775

5.  Congenital impatency of the nasolacrimal duct.

Authors:  D GUERRY; E L KENDIG
Journal:  Arch Ophthal       Date:  1948-02

6.  Congenital nasolacrimal system obstruction.

Authors:  B J Kushner
Journal:  Arch Ophthalmol       Date:  1982-04

7.  Congenital nasolacrimal duct obstruction in Japanese infants: its incidence and treatment with massage.

Authors:  S Noda; S Hayasaka; T Setogawa
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1991 Jan-Feb       Impact factor: 1.402

8.  Stepwise treatment paradigm for congenital nasolacrimal duct obstruction.

Authors:  Douglas R Casady; Dale R Meyer; John W Simon; George O Stasior; Jitka L Zobal-Ratner
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2006 Jul-Aug       Impact factor: 1.746

9.  Success rates of nasolacrimal duct probing at time intervals after 1 year of age.

Authors:  R M Robb
Journal:  Ophthalmology       Date:  1998-07       Impact factor: 12.079

10.  The natural course of congenital obstruction of the nasolacrimal duct.

Authors:  R A Petersen; R M Robb
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1978 Jul-Aug       Impact factor: 1.402

View more
  11 in total

1.  [Treatment of congenital lacrimal duct obstruction: A prospective clinical cohort study].

Authors:  J Heichel; F Bachner; A Schmidt-Pokrzywniak; H-G Struck; U Stuhlträger; T Bredehorn-Mayr
Journal:  Ophthalmologe       Date:  2015-10       Impact factor: 1.059

2.  Bicanalicular versus monocanalicular intubation after failed probing in congenital nasolacrimal duct obstruction.

Authors:  Mohammad Taher Rajabi; Najmeh Zavarzadeh; Alireza Mahmoudi; Mohammad Karim Johari; Seyedeh Simindokht Hosseini; Yalda Abrishami; Mohammad Bagher Rajabi
Journal:  Int J Ophthalmol       Date:  2016-10-18       Impact factor: 1.779

3.  Pediatric nasolacrimal duct obstruction-benefit of a combined therapeutic approach.

Authors:  Miloš Fischer; Iris-Susanne Horn; Mathias Otto; Mandy Pirlich; Andreas Dietz; Christian Mozet
Journal:  World J Pediatr       Date:  2017-05-24       Impact factor: 2.764

4.  Success rates of dacryoendoscopy-guided probing for recalcitrant congenital nasolacrimal duct obstruction.

Authors:  Masahiro Fujimoto; Ken Ogino; Hiroko Matsuyama; Chika Miyazaki
Journal:  Jpn J Ophthalmol       Date:  2016-04-27       Impact factor: 2.447

5.  Trends in congenital nasolacrimal duct obstruction surgical procedures in the United States from 2003 to 2016.

Authors:  Irma Muminovic; Won Yeol Ryu; Scott R Lambert
Journal:  J AAPOS       Date:  2021-09-29       Impact factor: 1.220

6.  Dacryoscintigraphic findings in the children with tearing.

Authors:  Hyung Chul Kim; A Ran Cho; Helen Lew
Journal:  Korean J Ophthalmol       Date:  2015-01-22

7.  Congenital nasolacrimal duct obstruction: Should we continue lacrimal massage till 1 year or perform an office probing at 6 months? A clinical decision analysis approach.

Authors:  Mihir Kothari; Vivek Rathod; Kruti Shah; Khushboo Shikhangi; Renu Singhania
Journal:  Indian J Ophthalmol       Date:  2017-02       Impact factor: 1.848

8.  Success rates of probing for congenital nasolacrimal duct obstruction at various ages.

Authors:  Marta Świerczyńska; Ewelina Tobiczyk; Piotr Rodak; Dorota Barchanowska; Erita Filipek
Journal:  BMC Ophthalmol       Date:  2020-10-08       Impact factor: 2.209

9.  Management of congenital nasolacrimal duct obstruction: results of a national survey of paediatric and oculoplastic ophthalmologists.

Authors:  Vidushi Golash; Harpreet Kaur; Sarju Athwal; Rebiye Chakartash; Masara Laginaf; Mona Khandwala
Journal:  Eye (Lond)       Date:  2020-09-16       Impact factor: 4.456

Review 10.  Congenital Nasolacrimal Duct Obstruction (CNLDO): A Review.

Authors:  Aldo Vagge; Lorenzo Ferro Desideri; Paolo Nucci; Massimiliano Serafino; Giuseppe Giannaccare; Andrea Lembo; Carlo Enrico Traverso
Journal:  Diseases       Date:  2018-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.